MedPath

Enhanced Clinics for Patients Diagnosed With Ankylosing Spondylitis and Psoriatic Arthritis

Withdrawn
Conditions
Psoriatic Arthritis
Spondylitis, Ankylosing
Registration Number
NCT04341233
Lead Sponsor
NHS Lothian
Brief Summary

The 19.5 months project will pilot the introduction of a hospital-based, nurse-led ankylosing spondylitis (AS) and psoriatic arthritis (PsA) service for patients being initiated on biologic therapy in NHS Lothian Edinburgh Western General Hospital.

It is anticipated that this new model of care will improve:

1. The time from referral for biologic therapy to initiation of treatment with a biological therapy due to the dedicated nurse to see patients

2. The management and monitoring of AS and PsA patients post commencement of treatment , in line with The National Institute for Health and Care Excellence (NICE) guidelines

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
170
Inclusion Criteria
  • Clinical diagnosis of AS or PsA
  • Referral for initiation of biological therapy by patients regular consultant
  • Age 18 years or older
  • Willing and able to give informed consent
Exclusion Criteria

· Unable to comply with study procedures

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Setup a nurse-led clinic3 months

Appointing a nurse and training in biologic and DMARD counselling, clinical measures and clinic administration.

Develop and setup a tool, an NHS Lothian Excel database19.5 months

Database enables trust to use the evaluated model of care to enable NHS Lothian to build an informed business case to fund the continuation of this service in the future and expand it to all patients in their current service.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath